261 related articles for article (PubMed ID: 24111943)
1. Methionine down-regulates TLR4/MyD88/NF-κB signalling in osteoclast precursors to reduce bone loss during osteoporosis.
Vijayan V; Khandelwal M; Manglani K; Gupta S; Surolia A
Br J Pharmacol; 2014 Jan; 171(1):107-21. PubMed ID: 24111943
[TBL] [Abstract][Full Text] [Related]
2. The miR-1906 mimic attenuates bone loss in osteoporosis by down-regulating the TLR4/MyD88/NF-κB pathway.
Xie H; Cao L; Ye L; Shan G; Song W
Physiol Int; 2021 Nov; 107(4):469-478. PubMed ID: 33410769
[TBL] [Abstract][Full Text] [Related]
3. GSH attenuates RANKL-induced osteoclast formation in vitro and LPS-induced bone loss in vivo.
Han B; Geng H; Liu L; Wu Z; Wang Y
Biomed Pharmacother; 2020 Aug; 128():110305. PubMed ID: 32485573
[TBL] [Abstract][Full Text] [Related]
4. Longan fruit increase bone mineral density in zebrafish and ovariectomized rat by suppressing RANKL-induced osteoclast differentiation.
Son Y; Lee EM; Lee DY; Lee JH; Oh S
Phytomedicine; 2019 Jun; 59():152910. PubMed ID: 30978650
[TBL] [Abstract][Full Text] [Related]
5. Antiosteoporotic activity of Davallia formosana.
Ko YJ; Wu JB; Ho HY; Lin WC
J Ethnopharmacol; 2012 Jan; 139(2):558-65. PubMed ID: 22155390
[TBL] [Abstract][Full Text] [Related]
6. The anti-osteoporotic effect of Yijung-tang in an ovariectomized rat model mediated by inhibition of osteoclast differentiation.
Kim T; Ha H; Shim KS; Cho WK; Ma JY
J Ethnopharmacol; 2013 Mar; 146(1):83-9. PubMed ID: 23219731
[TBL] [Abstract][Full Text] [Related]
7. Hydrogen gas protects against ovariectomy-induced osteoporosis by inhibiting NF-κB activation.
Wu G; Pan L; Sun J; Chen G; Wang S
Menopause; 2019 Jul; 26(7):785-792. PubMed ID: 31083022
[TBL] [Abstract][Full Text] [Related]
8. Anti-Osteoporotic Effect of Morroniside on Osteoblast and Osteoclast Differentiation In Vitro and Ovariectomized Mice In Vivo.
Lee CG; Kim J; Yun SH; Hwang S; Jeon H; Park E; Jeong SY
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638983
[TBL] [Abstract][Full Text] [Related]
9. Differences in osteoclast formation between proximal and distal tibial osteoporosis in rats with adjuvant arthritis: inhibitory effects of bisphosphonates on osteoclasts.
Shu G; Yamamoto K; Nagashima M
Mod Rheumatol; 2006; 16(6):343-9. PubMed ID: 17164994
[TBL] [Abstract][Full Text] [Related]
10. Andrographolide suppresses RANKL-induced osteoclastogenesis in vitro and prevents inflammatory bone loss in vivo.
Zhai ZJ; Li HW; Liu GW; Qu XH; Tian B; Yan W; Lin Z; Tang TT; Qin A; Dai KR
Br J Pharmacol; 2014 Feb; 171(3):663-75. PubMed ID: 24125472
[TBL] [Abstract][Full Text] [Related]
11. Calcitonin Induces Bone Formation by Increasing Expression of Wnt10b in Osteoclasts in Ovariectomy-Induced Osteoporotic Rats.
Hsiao CY; Chen TH; Chu TH; Ting YN; Tsai PJ; Shyu JF
Front Endocrinol (Lausanne); 2020; 11():613. PubMed ID: 33013696
[TBL] [Abstract][Full Text] [Related]
12. Kinsenoside prevents ovariectomy-induced bone loss and suppresses osteoclastogenesis by regulating classical NF-κB pathways.
Hsiao HB; Lin H; Wu JB; Lin WC
Osteoporos Int; 2013 May; 24(5):1663-76. PubMed ID: 23143538
[TBL] [Abstract][Full Text] [Related]
13. Alendronate rescued osteoporotic phenotype in a model of glucocorticoid-induced osteoporosis in adult zebrafish scale.
Pasqualetti S; Congiu T; Banfi G; Mariotti M
Int J Exp Pathol; 2015 Feb; 96(1):11-20. PubMed ID: 25603732
[TBL] [Abstract][Full Text] [Related]
14. A novel BRD4 inhibitor suppresses osteoclastogenesis and ovariectomized osteoporosis by blocking RANKL-mediated MAPK and NF-κB pathways.
Liu Y; Liu W; Yu Z; Zhang Y; Li Y; Xie D; Xie G; Fan L; He S
Cell Death Dis; 2021 Jun; 12(7):654. PubMed ID: 34175898
[TBL] [Abstract][Full Text] [Related]
15. KMUP-1 suppresses RANKL-induced osteoclastogenesis and prevents ovariectomy-induced bone loss: roles of MAPKs, Akt, NF-κB and calcium/calcineurin/NFATc1 pathways.
Liou SF; Hsu JH; Lin IL; Ho ML; Hsu PC; Chen LW; Chen IJ; Yeh JL
PLoS One; 2013; 8(7):e69468. PubMed ID: 23936022
[TBL] [Abstract][Full Text] [Related]
16. Cyperus Rotundus L. extract suppresses RANKL-induced osteoclastogenesis through NFATc1/c-fos downregulation and prevent bone loss in OVX-induced osteoporosis rat.
Kum CJ; Kim EY; Kim JH; Lee B; Min JH; Heo J; Kim JH; Yeom M; Sohn Y; Jung HS
J Ethnopharmacol; 2017 Jun; 205():186-194. PubMed ID: 28315458
[TBL] [Abstract][Full Text] [Related]
17. NF-κB pathway inhibition by anthrocyclic glycoside aloin is key event in preventing osteoclastogenesis in RAW264.7 cells.
Pengjam Y; Madhyastha H; Madhyastha R; Yamaguchi Y; Nakajima Y; Maruyama M
Phytomedicine; 2016 Apr; 23(4):417-28. PubMed ID: 27002412
[TBL] [Abstract][Full Text] [Related]
18. The genetic ablation or pharmacological inhibition of TRPV1 signalling is beneficial for the restoration of quiescent osteoclast activity in ovariectomized mice.
Rossi F; Bellini G; Torella M; Tortora C; Manzo I; Giordano C; Guida F; Luongo L; Papale F; Rosso F; Nobili B; Maione S
Br J Pharmacol; 2014 May; 171(10):2621-30. PubMed ID: 24308803
[TBL] [Abstract][Full Text] [Related]
19. The novel small molecule E0924G dually regulates bone formation and bone resorption through activating the PPARδ signaling pathway to prevent bone loss in ovariectomized rats and senile mice.
Li Y; Liu C; Han X; Sheng R; Bao L; Lei L; Wu Y; Li Q; Zhang Y; Zhang J; Wang W; Zhang Y; Li S; Wang C; Wei X; Wang J; Peng Z; Xu Y; Si S
Bioorg Chem; 2024 Jun; 147():107364. PubMed ID: 38636434
[TBL] [Abstract][Full Text] [Related]
20. Dietary n-3 fatty acids decrease osteoclastogenesis and loss of bone mass in ovariectomized mice.
Sun D; Krishnan A; Zaman K; Lawrence R; Bhattacharya A; Fernandes G
J Bone Miner Res; 2003 Jul; 18(7):1206-16. PubMed ID: 12854830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
